It was first characterized by Predrag Sikiric and colleagues at the University of Zagreb in the early 1990s, and a 2025 literature and patent review cataloged its effects across gastrointestinal, musculoskeletal, and neural models
The pathogenicity of the SsCm1 mutants on different hosts was significantly reduced compared with the UF-1 and the complemented strain, whereas no significant variations among these strains were detected in colony morphology, hyphal growth rate, compound appressorium formation, sclerotium development, OA production, and content of cell wall hydrolase (Fig
Many peptides are utilized in functional and integrative medicine, but I have found three in particular that I use in various forms, combinations, and doses for Ulcerative colitis treatment
KLOW peptide is a four-component research blend BPC-157 (50mg), TB-500 (10mg), KPV (10mg), GHK-Cu (10mg) 80mg total in a 3mL lyophilized vial